Patents by Inventor Li-Ming Zhou

Li-Ming Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ARTEMISININ-DERIVED TRIMERS AND TETRAMERS AND THEIR USE THEREOF
    Publication number: 20220275003
    Abstract: The present disclosure provides compositions comprising artemisinin-derived trimers and tetramers; methods of preparing these compositions; and methods for their use as medicaments.
    Type: Application
    Filed: May 12, 2022
    Publication date: September 1, 2022
    Inventors: MING ZHAO, LI-MING ZHOU
  • COMPOSITION CONTAINING ARTESUNATE
    Publication number: 20220273613
    Abstract: The present disclosure provides a corn position of artesunate, a process of preparing the same, and a method of treatment.
    Type: Application
    Filed: March 21, 2021
    Publication date: September 1, 2022
    Inventors: MING ZHAO, LI-MING ZHOU
  • Artemisinin-derived trimers and tetramers and their use thereof
    Patent number: 11358970
    Abstract: The present disclosure provides compositions comprising artemisinin-derived trimers and tetramers; methods of preparing these compositions; and methods for their use as medicaments.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: June 14, 2022
    Inventors: Ming Zhao, Li-Ming Zhou
  • Composition containing artesunate
    Patent number: 10987338
    Abstract: The present disclosure provides a composition of artesunate, a process of preparing the same, and a method of treatment.
    Type: Grant
    Filed: September 16, 2019
    Date of Patent: April 27, 2021
    Inventors: Ming Zhao, Li-Ming Zhou
  • ARTEMISININ-DERIVED TRIMERS AND TETRAMERS AND THEIR USE THEREOF
    Publication number: 20210079011
    Abstract: The present disclosure provides compositions comprising artemisinin-derived trimers and tetramers; methods of preparing these compositions; and methods for their use as medicaments.
    Type: Application
    Filed: November 21, 2018
    Publication date: March 18, 2021
    Inventors: MING ZHAO, LI-MING ZHOU
  • Salts of 5-aminolevulinic acid and derivatives
    Patent number: 10653653
    Abstract: The present disclosure provides new salts of 5-aminolevulinic acid (5-ALA) and new salts of 5-ALA esters, their preparation, formulation and use as photosensitizing agents in photodynamic therapy, diagnosis and cosmetic cares.
    Type: Grant
    Filed: January 24, 2017
    Date of Patent: May 19, 2020
    Inventors: Ming Zhao, Li-Ming Zhou
  • COMPOSITION CONTAINING ARTESUNATE
    Publication number: 20200022950
    Abstract: The present disclosure provides a composition of artesunate, a process of preparing the same, and a method of treatment.
    Type: Application
    Filed: September 16, 2019
    Publication date: January 23, 2020
    Inventors: MING ZHAO, LI-MING ZHOU
  • Composition containing artesunate
    Patent number: 10471042
    Abstract: The present disclosure provides a composition of artesunate, a process of preparing the same, and a method of treatment.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: November 12, 2019
    Inventors: Ming Zhao, Li-Ming Zhou
  • composition containing artesunate
    Publication number: 20190029996
    Abstract: The present disclosure provides a composition of artesunate, a process of preparing the same, and a method of treatment.
    Type: Application
    Filed: January 13, 2017
    Publication date: January 31, 2019
    Inventors: MING ZHAO, LI-MING ZHOU
  • SALTS OF 5-AMINOLEVULINIC ACID AND DERIVATIVES
    Publication number: 20190022044
    Abstract: The present disclosure provides new salts of 5-aminolevulinic acid (5-ALA) and new salts of 5-ALA esters, their preparation, formulation and use as photosensitizing agents in photodynamic therapy, diagnosis and cosmetic cares.
    Type: Application
    Filed: January 24, 2017
    Publication date: January 24, 2019
    Inventors: MING ZHAO, LI-MING ZHOU
  • Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation
    Patent number: 7750012
    Abstract: The present invention relates to a chemical genus of biaryl nitrogen-attached heterocycles that are inhibitors of LTA4H (leukotriene A4 hydrolase). The compounds have the general formula They are useful for the treatment and prevention and prophylaxis of inflammatory diseases and disorders.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: July 6, 2010
    Assignee: deCODE genetics ehf
    Inventors: Vincent Sandanayaka, Jasbir Singh, Li-Ming Zhou, Mark E. Gurney
  • BIARYL NITROGEN-HETEROCYCLE INHIBITORS OF LTA4H FOR TREATING INFLAMMATION
    Publication number: 20070149544
    Abstract: The present invention relates to a chemical genus of biaryl nitrogen-attached heterocycles that are inhibitors of LTA4H (leukotriene A4 hydrolase). The compounds have the general formula They are useful for the treatment and prevention and prophylaxis of inflammatory diseases and disorders.
    Type: Application
    Filed: August 3, 2006
    Publication date: June 28, 2007
    Applicant: DECODE CHEMISTRY, INC.
    Inventors: Vincent SANDANAYAKA, Jasbir SINGH, Li-Ming ZHOU, Mark E. GURNEY
  • Conantokins
    Patent number: 6515103
    Abstract: The present invention is directed to conantokin peptides, conantokin peptide derivatives and conantokin peptide chimeras, referred to collectively as conantokins, having 10-30 amino acids, including preferably two or more &ggr;-carboxyglutamic acid residues. The conantokins are useful for the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, neuroprotective agents or analgesic agents.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: February 4, 2003
    Assignees: University of Utah Research Foundation, Cognetix, Inc., Salk Institute
    Inventors: Fe C. Abogadie, Lourdes J. Cruz, Baldomero M. Olivera, Craig Walker, Clark Colledge, David R. Hillyard, Elsie Jimenez, Richard T. Layer, Li-Ming Zhou, Gregory S. Shen, R. Tyler McCabe, Jean E. Rivier
  • Use of conantokins
    Patent number: 6399574
    Abstract: The present invention is directed to the use of conantokin peptides, conantokin peptide derivatives and conantokin peptide chimeras, referred to collectively as conantokins, having 10-30 amino acids, including preferably two or more &ggr;-carboxyglutamic acid residues, for the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, neuroprotective agents or analgesic agents.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: June 4, 2002
    Assignees: University of Utah Research Foundation, Cognetix, Inc.
    Inventors: R. Tyler McCabe, Li-Ming Zhou, Richard T. Layer, Baldomero M. Olivera, J. Michael McIntosh
  • Process for producing an H2-CO gas mixture
    Patent number: 6284157
    Abstract: In a discharge reactor with a low-current gas discharge, an inlet gas made of a CH4—CO2 gas mixture is converted into a synthesis gas having an H2—CO gas mixture which has a higher energy content than the inlet gas. For a predeterminable synthesis gas volume ratio R=H2/CO, the requisite CO2 proportion in the inlet gas can be derived from a function curve (f) or calculated according to V=−4.76·R3+37.57·R2−99.13·R+105.39.
    Type: Grant
    Filed: December 28, 1998
    Date of Patent: September 4, 2001
    Assignee: ABB Research Ltd.
    Inventors: Baldur Eliasson, Ulrich Kogelschatz, Li-Ming Zhou
  • Use of conantokins for treating pain
    Patent number: 6277825
    Abstract: The present invention is directed to the use of conantokin peptides, conantokin peptide derivatives and conantokin peptide chimeras, referred to collectively as conantokins, having 10-30 amino acids, including preferably two or more &ggr;-carboxyglutamic acid residues, for the treatment of neurologic and psychiatric disorders, such as pain, e.g., as an analgesic agent.
    Type: Grant
    Filed: July 20, 1999
    Date of Patent: August 21, 2001
    Assignees: University of Utah Research Foundation, Cognetix, Inc.
    Inventors: Baldomero M. Olivera, J. Michael McIntosh, R. Tyler McCabe, Richard T. Layer, Li-Ming Zhou
  • Use of conantokins
    Patent number: 6172041
    Abstract: The present invention is directed to the use of conantokin peptides, conantokin peptide derivatives and conantokin peptide chimeras, referred to collectively as conantokins, having 10-30 amino acids, including preferably two or more &ggr;-carboxyglutamic acid residues, for the treatment of neurologic and psychiatric disorders, such as anticonvulsant agents, neuroprotective agents or analgesic agents.
    Type: Grant
    Filed: February 10, 1999
    Date of Patent: January 9, 2001
    Assignees: University of Utah Research Foundation, Cognetix, Inc.
    Inventors: R. Tyler McCabe, Li-Ming Zhou, Richard T. Layer, Baldomero M. Olivera, J. Michael McIntosh